![T-butyl-2-Β-(pyridin-2-yl)benzyl] Hydrazine Carboxylate CAS NO.:198904-85-7](/uploads/24095/small/t-butyl-2-pyridin-2-yl-benzyl-hydrazine15a84.png)
![(1S,5R,6S)-Ethyl 5-(pentan-3-yl-oxy)-7-oxa-bicyclo[4.1.0]hept-3-ene-3-carboxylate CAS NO 204254-96-6](/uploads/24095/small/-1s-5r-6s-ethyl-5-pentan-3-yl-oxy-7-oxa4864b.png)
![Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS:328086-60-8](/uploads/202224095/small/methyl-s-2-boc-amino-3-s-2-oxo-3-pyrrolidinyl04047704443.png)
![6,6-DiMethyl-3-azabicyclo[3.1.0]hexane Boceprevir Key InterMediate CAS：943516-54-9](/uploads/202224095/small/6-6-dimethyl-3-azabicyclo-3-1-0-hexane59255673929.png)
![N-[5-Bromomethyl-4-(4-fluorophenyl)-6-isopropylpyrimidine-2-yl]-N-methylmethane Sulfonamide CAS NO.799842-07-2](/uploads/202224095/small/n-5-bromomethyl-4-4-fluorophenyl-625079637964.png)
Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients and pharmaceutical intermediates, cooperative R & D, custom manufacturing, sales and service as well as import of pharmaceutical raw materials.
Products Categories
- Anti-Virus Drugs
- Anti Inflammatory Drugs
- Nirmatrelvir Intermediates
- Anti-hyperlipidemic Drugs
Various
Medicines
Learn More
Medicines
We're Committed to Top-Notch Quality
Company Profile
-
Export of APIs ,Food additive and Intermediates
-
Cooperative R & D and production of API and intermediates
-
API and intermediate registration and consulting services in China
-
Import and distribution of API and intermediates
Our Product
Products includes the following
• Export of APIs and intermediates, collaborative R&D and production;
• Registration and consulting services for APIs and intermediates in the country;
• Import and distribution of APIs and intermediates;
• Custom processing
Advanced Design, Technology Research,
Intelligent Manufacturing
Remains at the Forefront of Product Innovation Through Scientific Advancements.
-
0+Won over 100 international design awards including Red Dot Design Award and lFDesign Award -
0+Earned more than 4000 patents with the CAGR of over 35% in recent three years -
0+10000+ retail stores worldwide -
0+500000+ ㎡ intelligent manufacturing bases
Diverse Designs & Techniques to Meet
Your Custom Needs
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants.
-
Custom Product Design
Meticulous cleaning, polishing, and waxing to restore.
-
Rich Material Selection
Meticulous cleaning, polishing, and waxing to restore.
-
Custom Performance
Meticulous cleaning, polishing, and waxing to restore.
Partner Brands We Offer
First-class Support And
After-Sales Service
After-Sales Service
We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
-
Professional ability and rich experienceWe have a strong team and advanced technical strength. Providing customers with high-quality services is our core mission.Read More
-
Good reputation and word of mouthWe have always adhered to the principle of honest operation and won the trust and praise of our customers.Read More
-
High-quality service and comprehensive supportWe provide a full range of service support, including pre-sales consultation, technical support and after-sales serviceRead More
-
Innovative spirit and sustainable developmentWe focus on technological innovation and research and development, and constantly innovate to meet the ever-changing market and customer needs.Read More
Latest News
-
![Global First, China Debut: Yanhong Pharmaceutical's Non-Invasive Treatment For Cervical Precancer...]()
Mar 06, 2026Global First, China Debut: Yanhong Pharmaceutical's Non-Invasive Treatment For Cervical Precancer...(China, March 3, 2026) Yanhong Pharmaceutical (Stock Code: 688176.SH), a global innovative pharmaceutical company focused on urogenital tumors and women'... -
![Blockbuster Grand Slam! Roche’s Oral BTK Inhibitor Secures Third Phase III Trial Victory, Unveili...]()
Mar 05, 2026Blockbuster Grand Slam! Roche’s Oral BTK Inhibitor Secures Third Phase III Trial Victory, Unveili...On March 2, Roche officially announced that its investigational Bruton's tyrosine kinase (BTK) inhibitor, fenebrutinib, successfully met the primary endpoint... -
![New Advances in Anti-Aging Drugs]()
Feb 27, 2026New Advances in Anti-Aging DrugsIn recent years, with key breakthroughs in fundamental research such as cellular aging mechanisms and gene regulation in life sciences, a series of drugs or ...
